140 related articles for article (PubMed ID: 11985474)
1. Hematoporphyrin-derived soluble porphyrin-platinum conjugates with combined cytotoxic and phototoxic antitumor activity.
Lottner C; Bart KC; Bernhardt G; Brunner H
J Med Chem; 2002 May; 45(10):2064-78. PubMed ID: 11985474
[TBL] [Abstract][Full Text] [Related]
2. Soluble tetraarylporphyrin-platinum conjugates as cytotoxic and phototoxic antitumor agents.
Lottner C; Bart KC; Bernhardt G; Brunner H
J Med Chem; 2002 May; 45(10):2079-89. PubMed ID: 11985475
[TBL] [Abstract][Full Text] [Related]
3. Combined chemotherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin-platinum(II) conjugates.
Lottner C; Knuechel R; Bernhardt G; Brunner H
Cancer Lett; 2004 Jan; 203(2):171-80. PubMed ID: 14732225
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biodistribution and antitumor activity of hematoporphyrin-platinum(II) conjugates.
Kim YS; Song R; Hyun Kim D; Jun MJ; Sohn YS
Bioorg Med Chem; 2003 Apr; 11(8):1753-60. PubMed ID: 12659761
[TBL] [Abstract][Full Text] [Related]
5. Distribution and subcellular localization of a water-soluble hematoporphyrin-platinum(II) complex in human bladder cancer cells.
Lottner C; Knuechel R; Bernhardt G; Brunner H
Cancer Lett; 2004 Nov; 215(2):167-77. PubMed ID: 15488635
[TBL] [Abstract][Full Text] [Related]
6. A folate-conjugated platinum porphyrin complex as a new cancer-targeting photosensitizer for photodynamic therapy.
Yang M; Deng J; Guo D; Zhang J; Yang L; Wu F
Org Biomol Chem; 2019 May; 17(21):5367-5374. PubMed ID: 31106316
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium-porphyrin conjugates with cytotoxic and phototoxic antitumor activity.
Gianferrara T; Bergamo A; Bratsos I; Milani B; Spagnul C; Sava G; Alessio E
J Med Chem; 2010 Jun; 53(12):4678-90. PubMed ID: 20491441
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of novel platinum(II) complexes of glutamate tethered to hydrophilic hematoporphyrin derivatives.
Kim YS; Song R; Lee CO; Sohn YS
Bioorg Med Chem Lett; 2004 Jun; 14(11):2889-92. PubMed ID: 15125953
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
12. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and SAR studies of novel bicyclic antitumor platinum(IV) complexes.
Lorenzo J; Delgado A; Montaña ÁM; Mesas JM; Alegre MT; Rodríguez Mdel C; Avilés FX
Eur J Med Chem; 2014 Aug; 83():374-88. PubMed ID: 24980119
[TBL] [Abstract][Full Text] [Related]
14. Block copolymer micelles with pendant bifunctional chelator for platinum drugs: effect of spacer length on the viability of tumor cells.
Huynh VT; Quek JY; de Souza PL; Stenzel MH
Biomacromolecules; 2012 Apr; 13(4):1010-23. PubMed ID: 22324363
[TBL] [Abstract][Full Text] [Related]
15. Monofunctional BODIPY-Appended Imidazoplatin for Cellular Imaging and Mitochondria-Targeted Photocytotoxicity.
Raza MK; Gautam S; Garai A; Mitra K; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Sep; 56(18):11019-11029. PubMed ID: 28846407
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach.
Monti E; Gariboldi M; Maiocchi A; Marengo E; Cassino C; Gabano E; Osella D
J Med Chem; 2005 Feb; 48(3):857-66. PubMed ID: 15689170
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of novel thermosensitive platinum(II)-cyclotriphosphazene conjugates.
Song SC; Lee SB; Lee BH; Ha HW; Lee KT; Sohn YS
J Control Release; 2003 Jul; 90(3):303-11. PubMed ID: 12880697
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship of novel antitumoral platinum xanthate complexes.
Friebolin W; Schilling G; Zöller M; Amtmann E
J Med Chem; 2004 Apr; 47(9):2256-63. PubMed ID: 15084124
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
